Endo Slams DQ Bid For BakerHostetler Atty In Opioid MDL

By Emily Field · January 23, 2019, 6:33 PM EST

Endo Pharmaceuticals Inc. on Wednesday hit back at a motion to disqualify a BakerHostetler partner— and former U.S. attorney who worked on the opioid crisis— from bellwether cases in the opioid...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

In Re: National Prescription Opiate Litigation

Case Number

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022

Recent Articles By Emily

November 05, 2024
Target Inks Individual Deals Over 'Non-Drowsy' Flu Medicine
October 10, 2024
Animal Medication Co. Sued Over Dog Arthritis Treatment Risks
August 26, 2024
Rival Can't Avoid Drugmaker's False Ad Claim Over Pain Med
August 21, 2024
Spine Implant Caused Patient's TB, Suit Says
July 23, 2024
Meet The Lead Ozempic Lawyers
June 24, 2024
Ark. AG Sues Pharmacy Benefit Managers Over Opioids
May 03, 2024
6 States Strike $270M Opioid Deal With Amneal
April 17, 2024
FDA's Foot-Dragging On Menthol Ban Sparks Frustration
March 26, 2024
Opioid Public Nuisance Claims 'Unique,' Ohio High Court Told
March 25, 2024
What To Watch As Opioid Litigation Goes To Ohio High Court